Breast Cancer: Current Research
Open Access

Deep-inspiration breath hold; Intensity-modulated radiation therapy; Proton therapy

Introduction

Breast cancer is a complex disease that affects millions of women worldwide. While much research has focused on the genetic and cellular aspects of tumor development, emerging evidence suggests that the peripheral nervous system (PNS) also plays a significant role in breast cancer progression. The intricate interplay between breast cancer and the PNS is an area of active investigation, offering new insights into tumor development and potential therapeutic avenues. In this article, we delve into the fascinating relationship between breast cancer and the PNS, highlighting its impact on tumor development. Breast cancer is a complex and multifaceted disease that affects millions of individuals worldwide. While extensive research has focused on genetic and molecular factors contributing to breast cancer development, the role of the peripheral nervous system (PNS) in tumour progression has gained increasing recognition. This article aims to explore the intricate relationship between breast cancer and the PNS, while the role of the central nervous system (CNS) in cancer has been widely studied; recent investigations have unveiled the critical interplay between breast cancer and the peripheral nervous system (PNS). Highlighting its impact on tumour growth and potential implications for therapeutic interventions [1-3].

Discussion

A Pathway for Cancer Cell Spread Peripheral nerves can inadvertently serve as conduits for the spread of cancer cells, a process known as per neural invasion. In breast cancer, cancer cells can infiltrate nerve fibres, utilizing them as pathways to disseminate to distant sites. Per neural invasion promotes local tumour growth and facilitates metastasis, presenting a significant challenge in cancer management. Breast cancer is a complex and multifaceted disease that affects millions of individuals worldwide. Extensive research has focused on understanding the genetic and cellular mechanisms underlying its development and progression. However, recent studies have shed light on the involvement of the peripheral nervous system (PNS) in breast cancer, revealing a previously underappreciated aspect of its pathogenesis. The peripheral nervous system consists of a network of nerves that extends beyond the brain and spinal cord, reaching various tissues and organs throughout the body, including the breast. Traditionally, the PNS has been associated with its sensory and motor functions, transmitting signals between the central nervous system and peripheral tissues. However, emerging evidence suggests that the PNS plays a significant role in breast cancer biology. One important aspect of the PNS involvement in breast cancer is perineural invasion. Perineural invasion occurs when cancer cells infiltrate and utilize peripheral nerves as conduits for local spread and distant metastasis. The nerves provide a protective niche for cancer cells, facilitating their survival, proliferation, and migration to other sites. Perineural invasion has been associated with poor prognosis and increased risk of recurrence in breast cancer patients. The interaction between breast cancer cells and the PNS extends beyond perineural invasion. Neurotrophic factors, which are molecules that support the growth and survival of nerve cells, have been found to influence breast cancer growth and progression. Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are examples of neurotrophic factors that are present in the breast tissue. These factors can stimulate the growth and survival of breast cancer cells, promote angiogenesis (the formation of new blood vessels to support tumour growth), and contribute to the development of a tumor-promoting microenvironment. The PNS produces a range of neurotropic factors, including nerve growth factor (NGF) and brain-derived neurotropic factor (BDNF), which plays vital roles in nerve cell growth, survival, and function. However, certain neurotropic factors also have tumourpromoting effects. NGF and BDNF can stimulate the growth and survival of cancer cells, as well as promote angiogenesis, thereby facilitating the development of breast tumours. Neurotrophic factors are a group of molecules that play essential roles in the development, survival, and function of neurons in the peripheral nervous system (PNS) and central nervous system (CNS). However, emerging evidence suggests that these factors also have significant implications for breast cancer growth and progression. Neurotrophic factors, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), can influence various aspects of breast cancer biology, including cell proliferation, survival, angiogenesis, and metastasis [4-5].

One of the primary effects of neurotrophic factors in breast cancer is the promotion of cell proliferation and survival. NGF and BDNF, among others, have been shown to stimulate the growth of breast cancer cells through activation of specific signaling pathways. These factors bind to their respective receptors, such as TrkA for NGF and TrkB for BDNF, leading to the activation of downstream signaling cascades, including the MAPK and PI3K/Akt pathways. Activation of these pathways promotes cell division, inhibits apoptosis (programmed cell death), and enhances cell survival. The peripheral nerves are closely intertwined with the immune system, and this intricate crosstalk significantly influences tumour development. Neural signals can modulate immune responses, and alterations in this communication impact tumour growth and metastasis. Sympathetic nerves release neurotransmitters that affect immune cell activity, creating an immunosuppressive microenvironment that supports tumour growth. Neural-immune interactions play a critical role in the development and progression of breast cancer. The peripheral nervous system (PNS) and the immune system communicate bidirectionally through a complex network of neural and immune cells, signaling molecules, and receptors. These interactions influence various aspects of breast cancer, including tumor growth, immune responses, and metastasis.The sympathetic nervous system (SNS), a division of the autonomic nervous system, has been extensively studied in the context of neural-immune interactions in breast cancer. The SNS releases neurotransmitters, such as norepinephrine, which can bind to adrenergic receptors on immune cells. Activation of adrenergic receptors on immune cells can modulate their function and behaviour. For instance, it has been observed that norepinephrine can suppress the activity of natural killer (NK) cells, cytotoxic T lymphocytes, and dendritic cells, thereby impairing their ability to recognize and eliminate cancer cells [6-8].

Furthermore, sympathetic nerve fibers can directly innervate lymphoid organs and tumor microenvironments, allowing for the release of neurotransmitters in close proximity to immune cells. This localized release of neurotransmitters can influence immune cell recruitment, activation, and polarization. The SNS can promote the recruitment of pro-tumorigenic immune cells, such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), while inhibiting the infiltration and activation of anti-tumor immune cells, such as cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. Breast cancer involving the PNS often leads to pain and neurological symptoms. Tumour infiltration into nerves can cause neuropathic pain, which significantly affects the quality of life for patients. Managing these symptoms and addressing the underlying mechanisms are crucial components of comprehensive cancer care. The impact of peripheral nervous system (PNS) interaction on pain and quality of life in breast cancer patients is a significant consideration in understanding the comprehensive effects of the disease. Breast cancer-related pain can arise from various sources, including tumor infiltration into peripheral nerves, surgical interventions, chemotherapy-induced neuropathy, and radiation therapy. The presence of pain can have a profound impact on the physical, psychological, and social well-being of patients. Neuropathic pain, specifically, is a common and challenging symptom experienced by breast cancer patients. Tumor infiltration into peripheral nerves can lead to nerve compression, inflammation, and damage, resulting in neuropathic pain. This type of pain is characterized by abnormal sensations such as shooting or burning pain, tingling, numbness, and hypersensitivity in the affected areas. Neuropathic pain can be persistent, severe, and often difficult to manage, significantly impacting patients’ daily functioning and quality of life [9].

The presence of pain in breast cancer patients can limit mobility, impair sleep, reduce overall physical activity, and contribute to functional disability. It can also affect emotional well-being, leading to anxiety, depression, and decreased overall quality of life. The constant burden of pain can hinder the ability to engage in social activities, fulfill personal responsibilities, and maintain interpersonal relationships. Consequently, the psychosocial impact of pain on patients should not be underestimated. Effective pain management strategies are crucial for improving the quality of life for breast cancer patients. A multidimensional approach that combines pharmacological interventions, physical therapies, psychosocial support, and integrative therapies should be considered. Medications such as analgesics, opioids, anticonvulsants, and antidepressants can be prescribed to alleviate pain. Non-pharmacological interventions, including physical therapy, acupuncture, transcutaneous electrical nerve stimulation (TENS), and relaxation techniques, can also be beneficial in managing pain and improving functional capacity. In conclusion, the interaction between breast cancer and the peripheral nervous system (PNS) plays a significant role in tumour development and progression. The PNS, traditionally known for its sensory and motor functions, has emerged as an important player in breast cancer biology, impacting various aspects of the disease. Perineural invasion, characterized by cancer cells infiltrating and utilizing peripheral nerves as pathways for local spread and distant metastasis, is a crucial mechanism in tumour development. Understanding the cellular and molecular processes involved in perineural invasion can help identify novel therapeutic targets and improve patient outcomes. Neurotrophic factors, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), have been found to influence breast cancer growth and progression [10].

Conclusion

Their ability to promote cell proliferation, survival, angiogenesis, and metastasis underscores their potential as therapeutic targets in breast cancer treatment. Further research is needed to explore the specific mechanisms by which neurotrophic factors impact tumour development and to develop targeted therapies that disrupt these interactions. The neural-immune crosstalk in breast cancer is another crucial aspect of PNS involvement. The bidirectional communication between the PNS and the immune system influences tumor growth, immune responses, and the development of pain within the tumor microenvironment. Understanding and manipulating these neuralimmune interactions hold promise for enhancing anti-tumor immune responses and improving treatment outcomes. Moreover, the impact of PNS interaction on pain and quality of life in breast cancer patients cannot be overlooked. Neuropathic pain resulting from tumor infiltration into peripheral nerves significantly affects patients’ physical and emotional well-being. Efforts to address PNS-related pain and improve symptom management are essential for enhancing the overall quality of life for breast cancer patients.

Acknowledgment

None

Conflict of Interest

None

1. Sung H, Ferlay J, Siegel RL, Laversanne M (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209-249.

Indexed at, Google Scholar, Crossref

2. Maishman T, Cutress RI, Hernandez A (2017) Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study. Ann Surg 266:165-172.

Indexed at, Google Scholar, Crossref

3. Tufail M, Cui J, Wu C (2022) Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches. Am J Cancer Res 12:2920-2949.

Indexed at, Google Scholar, Crossref

4. Li Y, Gao X, Yu Z, Liu B, Pan W, Li N (2018) Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy. ACS Appl Mater Interfaces 10:15461-15466.

Indexed at, Google Scholar, Crossref

5. Ye P, Feng L, Shi S, Dong C (2022) The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers (Basel) 14:2101.

Indexed at, Google Scholar, Crossref

6. Xue ST, Zheng B, Cao SQ, Ding JC (2022) Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis. Mol Cancer 21:69.

Indexed at, Google Scholar, Crossref

7. 7Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, et al. (2021) Long non-coding RNAs in the doxorubicin resistance of cancer cells. Cancer Lett 508:104-114.

Indexed at, Google Scholar, Crossref

8. Meijer D, van Agthoven T, Bosma PT, Nooter K (2006) Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Mol Cancer Res. 4:379-386.

Indexed at, Google Scholar, Crossref

Indexed at, Google Scholar, Crossref

9. Wang X, He H, Rui W, Xie X (2020) Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer. Onco Targets Ther 13:2483-2490.

Indexed at, Google Scholar, Crossref

10. Ouyang S, Zhou X, Chen Z (2019) LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int 19:72.

Indexed at, Google Scholar, Crossref